FRANCISCA IFESINACHUKWU: Open Payments
NPI 1558475335 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,833 in 251 payments from 21 companies in 2025. Trend: 2023 $5,968 · 2024 $12,461 · 2025 $5,833
Food & beverage: $5,763Education: $70
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 28 | $684 |
| Alkermes, Inc. | 23 | $591 |
| E.R. Squibb & Sons, L.L.C. | 16 | $491 |
| ABBVIE INC. | 23 | $466 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $436 |
| Neurocrine BioSciences, Inc. | 13 | $397 |
| Janssen Pharmaceuticals, Inc | 12 | $396 |
| Axsome Therapeutics, Inc. | 17 | $354 |
| Teva Pharmaceuticals USA, Inc. | 19 | $327 |
| Lundbeck LLC | 16 | $321 |
Products named: REXULTI, CAPLYTA, ARISTADA, INGREZZA, COBENFY, SPRAVATO, VRAYLAR, FANAPT.
Industry payments across TX — which companies pay providers there.
